Too small for concern? Public health and nanotechnology

Diana Bowman, Michael Fitzharris

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

While advances in nanotechnology promise to deliver significant benefits to many aspects of health care, there is increasing concern that regulatory regimes do not adequately capture the potential risks associated with this new technology. Concerns have arisen due to preliminary evidence suggesting that some engineered nanoparticles may display undesirable toxicological properties, presenting potential risks to human and environmental health and safety. Within this context, the role of Australia's National Industrial Chemicals and Assessment Scheme and the Therapeutic Goods Administration in regulating nano-based substances is explored. Drawing on earlier regulatory failures, combined with the scientific uncertainty surrounding nanotechnology, this article recommends that Australia adopt a proactive regulatory approach to nanotechnology through amendments to present legislative regimes. The approach articulated in this article strikes a balance between the current approach and that of the European Union's comprehensive new chemicals regime. Immediate regulatory change is called for in order to ensure that the health of the Australian public is adequately protected over the coming years.

Original languageEnglish (US)
Pages (from-to)382-384
Number of pages3
JournalAustralian and New Zealand Journal of Public Health
Volume31
Issue number4
DOIs
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Nanotechnology
Public Health
Environmental Health
European Union
Nanoparticles
Toxicology
Uncertainty
Technology
Delivery of Health Care
Safety
Therapeutics

Keywords

  • Human health
  • Nanotechnology
  • Personal care products
  • Regulation

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Too small for concern? Public health and nanotechnology. / Bowman, Diana; Fitzharris, Michael.

In: Australian and New Zealand Journal of Public Health, Vol. 31, No. 4, 08.2007, p. 382-384.

Research output: Contribution to journalArticle

@article{213e1e66b8ae41e795a25454a75d6f45,
title = "Too small for concern? Public health and nanotechnology",
abstract = "While advances in nanotechnology promise to deliver significant benefits to many aspects of health care, there is increasing concern that regulatory regimes do not adequately capture the potential risks associated with this new technology. Concerns have arisen due to preliminary evidence suggesting that some engineered nanoparticles may display undesirable toxicological properties, presenting potential risks to human and environmental health and safety. Within this context, the role of Australia's National Industrial Chemicals and Assessment Scheme and the Therapeutic Goods Administration in regulating nano-based substances is explored. Drawing on earlier regulatory failures, combined with the scientific uncertainty surrounding nanotechnology, this article recommends that Australia adopt a proactive regulatory approach to nanotechnology through amendments to present legislative regimes. The approach articulated in this article strikes a balance between the current approach and that of the European Union's comprehensive new chemicals regime. Immediate regulatory change is called for in order to ensure that the health of the Australian public is adequately protected over the coming years.",
keywords = "Human health, Nanotechnology, Personal care products, Regulation",
author = "Diana Bowman and Michael Fitzharris",
year = "2007",
month = "8",
doi = "10.1111/j.1753-6405.2007.00092.x",
language = "English (US)",
volume = "31",
pages = "382--384",
journal = "Australian and New Zealand Journal of Public Health",
issn = "1326-0200",
publisher = "Public Health Association of Australia Inc.",
number = "4",

}

TY - JOUR

T1 - Too small for concern? Public health and nanotechnology

AU - Bowman, Diana

AU - Fitzharris, Michael

PY - 2007/8

Y1 - 2007/8

N2 - While advances in nanotechnology promise to deliver significant benefits to many aspects of health care, there is increasing concern that regulatory regimes do not adequately capture the potential risks associated with this new technology. Concerns have arisen due to preliminary evidence suggesting that some engineered nanoparticles may display undesirable toxicological properties, presenting potential risks to human and environmental health and safety. Within this context, the role of Australia's National Industrial Chemicals and Assessment Scheme and the Therapeutic Goods Administration in regulating nano-based substances is explored. Drawing on earlier regulatory failures, combined with the scientific uncertainty surrounding nanotechnology, this article recommends that Australia adopt a proactive regulatory approach to nanotechnology through amendments to present legislative regimes. The approach articulated in this article strikes a balance between the current approach and that of the European Union's comprehensive new chemicals regime. Immediate regulatory change is called for in order to ensure that the health of the Australian public is adequately protected over the coming years.

AB - While advances in nanotechnology promise to deliver significant benefits to many aspects of health care, there is increasing concern that regulatory regimes do not adequately capture the potential risks associated with this new technology. Concerns have arisen due to preliminary evidence suggesting that some engineered nanoparticles may display undesirable toxicological properties, presenting potential risks to human and environmental health and safety. Within this context, the role of Australia's National Industrial Chemicals and Assessment Scheme and the Therapeutic Goods Administration in regulating nano-based substances is explored. Drawing on earlier regulatory failures, combined with the scientific uncertainty surrounding nanotechnology, this article recommends that Australia adopt a proactive regulatory approach to nanotechnology through amendments to present legislative regimes. The approach articulated in this article strikes a balance between the current approach and that of the European Union's comprehensive new chemicals regime. Immediate regulatory change is called for in order to ensure that the health of the Australian public is adequately protected over the coming years.

KW - Human health

KW - Nanotechnology

KW - Personal care products

KW - Regulation

UR - http://www.scopus.com/inward/record.url?scp=34548038817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548038817&partnerID=8YFLogxK

U2 - 10.1111/j.1753-6405.2007.00092.x

DO - 10.1111/j.1753-6405.2007.00092.x

M3 - Article

VL - 31

SP - 382

EP - 384

JO - Australian and New Zealand Journal of Public Health

JF - Australian and New Zealand Journal of Public Health

SN - 1326-0200

IS - 4

ER -